Carcinoid Therapy 90Y-DOTATOC

 

 

 

 

 

 

 

 

Cuadro de texto:  (***)                    Radiation Doses          (*) Total of 4 to 6 doses, each one every 6-10 weeks.                                 (***) 

            Power penetration of  Itrium-90 may reach  150 cell diameter distance (10 mm).

References:

1) Lisa Bodei, Marta Cremonesi, Chiara Grana, Paola Rocca, Mirco Bartolomei, Marco Chinol, Giovanni Paganelli. Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2004) 31:1038–1046.

 

Home       Index          Therapy Carcinoid          Therapy Carcinoid Radiotracers